• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/40

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

40 Cards in this Set

  • Front
  • Back

Acute bronchitis PE

No evidence of lung consolidation:


clear to auscultation


Resonance


rhonchi clear with cough


afebrile to low grade temp - viral


higher temp - bact

Tx for acute bronchitis

Viral - MOST - supportive




bacterial:


macrolide


doxy


TMP/SMX

Asthma manifestations

narrowing of airways


hypertrophy of smooth muscle


mucosal edema


thickeninc of epithelial basement membrane


hypertrophy of mucusglands


acute inflammation


plugging of airways by thick,viscid mucus

Pulses paradoxus

decrease in systolic B/P with inspiration


>12 mmHg

SS Asthma

resp rate>28


pulse>110


pulses parodoxus


hyperresonance


cough

Ominous signs asthma

fatigue


absent breath sounds


paradoxical chest wall movement


inability to maintain recumbency


cyanosis

PFT changes after bronchodialator Asthma

15% improvement in FVC or FEV1


25% improvement of FEF 25/75




Consider hospitalization:


initial FEV1 <30% predictive


improvement after bronchodilator, but still < 40% predicted



Peak flows

measure FEV at home

Stepwise management of asthma

1. SABA (albuterol) PRN


2. ICS (Budesonide/Pulmocort


triamsinolone/Azmacort)


3. SABA (albuterol) for breakthrough


4. Increase ICS (pulmicort Azmacort) or


LABA (Salmeterol/Serevent)


5. Inhaled anticholinergics


(Ipratropium/Atrovent)


6. Orals - antileukotrienes



SABA

Short acting B2 adrenergic agonist




SABA = Albuterol

Inhaled corticosteroid (ICS)

ICS = cort




budesonide - Pulmicort


triamcinolone - Azmacort

LABA

long acting B2 Adrenergic agonist




LABA = salmeterol - serevent

Inhaled anticholinergic

inhaled anticholinergic = ipratropium/atrovent

Chronic bronchitis dx

excessive secretion of bronchial mucus


productive cough for 3 months or more


in 2 consecutive years

Emphysema def

abnormal


permanent


enlargement of alveoli

Chronic bronchitis ss

Intermittent


copious sputum (purulent)


stocky


percussion normal


younger


hyperinflation on CXR

Emphysema ss

Progressive, constant


older


mild sputum (clear)


thin/wasted


Percussion hyperresonant



OP tx COPD

anticholinergic = ipratropium


to help manage secretions

CAPnumonia agent

strep pneumoniae

Typical pneumonia ss

shaking chills


purulent sputum


lung consolidation


malaise


increased fremitus

Atypical pneumonia ss

cough (unrelenting)


headache


sorethroat


excessive sweating


fever


soreness in chest

atypical pneumonia pathogen

legionella


mycoplasma


chlamydophilapheumoniae

Mgmt CAP young/healthy

Macrolides:


azithromycin


clarithromycin


erythromyicn


doxycycline

Mgmt CAP older/sicker

Resp Flouroquinolone:




Levofloxacin


Moxifloxacin


Gemifloxacin

Night sweats - think:

TB


menopause


lymphoma


AIDS


Endocarditis

TB definitive dx

Culture of M. Tuberculosis X3

Confirmatory test TB

+ CXR


+Culture





TB labs

culture (definitive)


AFB (presumptive of active)


small homogeneous infiltrate upper lobes




PPD shows exposure Not diagnostic!

Meds for TB

INH
Rifampin


Pyrazinamide




ethambutol or streptomycin




if fully susceptible to INH and RIF, can d/c ethambutol or strepto

TB treatment duration

Two months:


INH


Rifampin


Pyrazinamide



Additional four months:


INH


RIF




minimum 6 months


HIVs for 9 months

monitoring TB therapy

weekly sputum smears for 6 weeks


watch for resistance

TB treatment monitoring

labs: LFT, CBC, cr




ethambutol:


visual acuity


red/green color blindness

PPD

5 mm - HIV, contacts, + CXR




10 mm - immigrants, high risk groups, health care workers




15 mm - everyone else

FVC


FEV1


FEV 25-75


PEFR

Measure airflow




Obstructive disease




asthma


chronic bronchitis


emphysema

TLC


FRC


RV

measure volumes




restrictive diseases:




pneumonia


pulmonary fibrosis


sarcoid


lung resection

Pleural effusions:

transudates - clear


exudates - cream (high protein)


empyema - pus


hemorrhagic - blood

Most common pathogens in pneumonia in elderly

s. pneumoniae


h. influenza


M. catarrhalis


Klebsiella




staph aureus

CXR findings in elderly - bacterial

Bronchopneumonia


lobar pneumonia


other locations



CXR findings in elderly - viral

bilateral interstitial infiltrates



Aspiration pneumonia CXR findings

localized to Right middle lobe


or diffuse involvement